Research: EHR Predictive Model Outperforms ED Social Needs Questionnaire
Regenstrief’s Joshua Vest, Ph.D., M.P.H., discusses potential advantages of using a predictive model to predict future need for health-related social services
Read More
How automation can reduce administrative costs in healthcare
According to a new report by the American Hospital Association, administrative costs now make up over 40% of total hospital expenses. Hospitals and health systems spend around $40 billion annually on billing and collections alone. For revenue cycle managers, the pressure is building as administrative tasks like insurance eligibility verification, claims management and payment processing…
How Narrow or Broad Are ACA Marketplace Physician Networks?
This report examines the share of doctors participating in the provider networks of Qualified Health Plans (QHPs) offered in the individual market in the federal and state Marketplaces in 2021, and how network breadth affected costs for enrollees.
GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings
GoodRx announced a new e-commerce solution starting with over-the-counter birth control pill Opill. It also is offering new affordability programs for menopause medications with Pfizer. The post GoodRx Expands Women’s Health Options with New Birth Control and Menopause Offerings appeared first on MedCity News.
Journalists Analyze Issues of the Day: RFK Jr., Bird Flu, L.A. Fires
KFF Health News senior correspondent Arthur Allen discussed what to watch for in Robert F. Kennedy Jr.’s confirmation hearings for secretary of Health and Human Services on CBS News Chicago on Jan. 29. Click here to watch Allen on CBS News Chicago Read Allen’s “What RFK Jr. Might Face in His Nomination Hearings This Week”…
Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval
Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…
How We Can Prevent Healthcare Associated Infections
As hospitals nationwide search to improve the cleanliness of their facilities, infection control continues to be one of their biggest challenges. The challenge of preventing healthcare associated infections persists for several reasons: pathogens have become more resistant; patient flow demands have put added pressure to quickly clean and disinfect patient rooms; and human error, partly…
FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca
SpringWorks Therapeutics’ Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
Targeting the Blast Radius: Why Spatial AI Diagnostics Are Crucial for Maximizing the Impact of Antibody-Drug Conjugates
As the field of oncology evolves, we need to shift away from traditional binary “yes-no” biomarkers to a more nuanced, spatial understanding of tumor biology. This approach will allow for more personalized treatment plans that are tailored to the unique characteristics of each patient’s tumor. The post Targeting the Blast Radius: Why Spatial AI Diagnostics…
The Evolving Landscape of Medicaid and CHIP: Implications for Children’s Oral Health
Medicaid and CHIP facilitate necessary access to oral health services, which helps to bridge the gap in dental care for children from low- and moderate-income families. By providing coverage, it ensures that socioeconomic status does not hinder a child’s ability to receive necessary dental services. The post The Evolving Landscape of Medicaid and CHIP: Implications…